Asociación entre índice tobillo-brazo y rendimiento cognitivo en participantes del estudio PREDIMED-Plus: estudio transversal

Identificador:  imarina:8263015

Handle: https://hdl.handle.net/20.500.11797/imarina8263015

Autores:  Lopez, Meritxell; Rios, Angel; Romaguera, Dora; Martinez-Gonzalez, Miguel Angel; Fernandez-Aranda, Fernando; Salas-Salvado, Jordi; Corella, Dolores; Fito, Montserrat; Vioque, Jesus; Alonso-Gomez, Angel M; Crespo-Oliva, Edelys; Martinez, J Alfredo; Serra-Majem, Luis; Estruch, Ramon; Tinahones, Francisco J; Lapetra, Jose; Pinto, Xavier; Tur, Josep A; Garcia-Rios, Antonio; Bueno-Cavanillas, Aurora; Gaforio, Jose J; Matia-Martin, Pilar; Daimiel, Lidia; Sanchez-Rodriguez, Ruben; Vidal, Josep; Sanz-Martinez, Enrique; Ros, Emilio; Toledo, Estefania; Barrubes, Laura; Barragan, Rocio; de la Torre, Rafael; Fiol, Miquel; Gonzalez-Palacios, Sandra; Sorto-Sanchez, Carolina; Martin-Ruiz, Maria Victoria; Zulet, Maria Angeles; Diaz-Collado, Fatima; Casas, Rosa; Fernandez-Garcia, Jose Carlos; Santos-Lozano, Jose Manuel; Mallorqui-Bague, Nuria; Argelich, Emma; Lecea, Oscar; Paz-Graniel, Indira; Sorli, Jose, V; Cuenca, Aida; Munuera, Susana; Hernandis-Marsan, Maria Vicenta; Vaquero-Luna, Jessica; Ruiz-Canela, Miguel; Camacho-Barcia, Lucia; Jimenez-Murcia, Susana; Castaner, Olga; Yanez, Aina M

Resumen:
© 2020 Sociedad Española de Cardiología Introduction and objectives: The ankle-brachial index (ABI) is an indicator of peripheral artery disease (PAD). The aim of this study was to assess the association between PAD, measured with the ABI, and cognitive function in persons with overweight or obesity and metabolic syndrome. Methods: Cross-sectional study conducted with baseline data from the PREDIMED-Plus study, which included 4898 participants (after exclusion of those without ABI measurements) aged between 55 and 75 years, and with overweight or obesity and metabolic syndrome. At the baseline assessment, we measured the ABI with a standardized protocol and assessed the presence of other cardiovascular risk factors (eg, diabetes, dyslipidemia, hypertension). Cognitive function was evaluated using several tests validated for the Spanish population (mini-mental state examination [MMSE], phonological and semantic verbal fluency test, WAIS-III working memory index [WMI], parts A and B of the trail making test (TMT), and clock drawing test). Generalized linear models were used to assess the association between the ABI and cognitive function. Results: Among the participants, 3.4% had PAD defined as ABI ≤ 0.9, and 3.3% had arterial calcification defined as ABI ≥ 1.4. PAD was associated with age, systolic blood pressure and obesity indicators, while arterial calcification was also associated with obesity and diabetes. No significant associations were observed between cognitive function and ABI or PAD. Conclusions: In our sample, the presence of PAD increased with age, blood pressure, and obesity. No significant association was observed between ABI, PAD, or cognitive function.